Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Hypoglycaemia

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Treat a bedside glucose below 4.0 mmol/L in a hospital patient immediately. If consciousness, airway protection or swallowing is impaired, summon urgent help, use ABCDE, stop oral intake and follow the current JBDS-aligned local parenteral pathway. Do not delay treatment for venous confirmation, and investigate any failure to recover as possible persistent neuroglycopenia or another emergency.

Synopsis

Recognise and treat low glucose promptly while finding the cause, preventing recurrence and preserving essential background diabetes therapy safely.

  • Think ‘four is the floor’: a capillary reading below 4.0 mmol/L requires action in an adult inpatient even when symptoms are subtle or absent.
  • Choose treatment by consciousness and swallow safety, not by the number alone; oral carbohydrate is unsafe in a drowsy, fitting or uncooperative patient.
  • For a conscious cooperative adult, JBDS uses 15–20 g rapid-acting carbohydrate followed by a glucose recheck after 10–15 minutes and repeat treatment if still low.
  • Once glucose is above 4.0 mmol/L and the person has recovered, give longer-acting carbohydrate or the planned meal and review the medicine that created risk.
  • Sulfonylurea and long-acting insulin hypoglycaemia may recur for 24–36 hours, especially with renal impairment; a single normal result is not a discharge test.
  • Glucagon may be less effective after repeated episodes, prolonged fasting, alcohol excess, liver disease or sulfonylurea exposure, so arrange reliable glucose delivery and monitoring.
  • During an active intravenous insulin infusion, pause it while treating the low glucose and restart safely once corrected according to the indication and local chart.
  • Document precipitant, severity, awareness, assistance required and prevention changes; provide driving advice when the event meets current DVLA relevance.

Key red flags

Autonomic warning

Sweating, tremor, hunger, palpitations, tingling or anxiety may precede cognitive impairment and provide a window for self-treatment when swallowing remains safe.

Neuroglycopenia

Irritability, bizarre behaviour, confusion, dysarthria, focal-looking weakness, seizure or reduced consciousness can mimic stroke or intoxication, so glucose belongs in every acute neurological assessment.

Prolonged drug effect

Renal decline, sulfonylurea use, long-acting insulin, administration error or reduced intake predicts recurrence and often warrants extended observation and specialist medication adjustment.

Alternative or additional emergency

Persistent coma, focal deficit, fever, trauma, toxic exposure or failure to improve after glucose correction means another diagnosis must be assessed in parallel.

Investigation priorities

01
Immediate capillary blood glucoseFirst step

Identify a reversible cause of acute behavioural, neurological or autonomic symptoms at the bedside.

Management branches

ConsciousTreat when swallowing is safe

Glucose is below 4.0 mmol/L and the adult is alert, cooperative and able to swallow safely.

  1. Give 15–20 g rapid-acting carbohydrate using a stocked option compatible with swallowing ability and any fluid or renal restriction, following the local JBDS-aligned chart.
  2. Recheck capillary glucose after 10–15 minutes; if it remains below 4.0 mmol/L, repeat the rapid treatment and reassess, using the escalation route if three cycles fail.
  3. After recovery, give a longer-acting carbohydrate snack or planned meal, resume appropriate diabetes treatment safely and investigate why supply and insulin action became mismatched.

Key medicines

Rapid-acting oral carbohydrateGive 15–20 g of rapid-acting carbohydrate to a conscious cooperative adult, then recheck glucose after 10–15 minutes and repeat if it remains below 4.0 mmol/L, using the current local JBDS-aligned options.Do not give orally with reduced consciousness, seizure, unsafe swallow or aspiration risk. Choose a preparation compatible with fluid restriction and swallowing difficulty; chocolate and other high-fat foods act too slowly for initial rescue.
Intravenous glucose for severe hypoglycaemiaJBDS lists 100 mL of 20% glucose over 15 minutes or 200 mL of 10% glucose over 15 minutes for an adult when intravenous treatment is required; prescribe the stocked concentration on the live local chart.Confirm concentration and line patency, monitor for extravasation and fluid considerations, and recheck glucose promptly. Avoid confusing different strengths or giving an unprescribed rapid bolus; follow resuscitation and local medicines policy.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • JBDS 01 hospital hypoglycaemia guidelineCurrent official adult inpatient definitions, oral and parenteral rescue, reassessment and recurrence guidance.
  • NICE NG17 type 1 diabetes recommendationsHypoglycaemia education, awareness, technology and insulin-management recommendations.
  • NICE NG28 type 2 diabetes recommendationsPerson-centred glycaemic targets and treatment review relevant to prevention.
  • DVLA diabetes fitness to drive guidanceCurrent statutory medical standards and definitions relevant after severe or recurrent hypoglycaemia.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom